Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial (Q34986932)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial (English)

1 reference

Europe PubMed Central

5 August 2017

phase I clinical trial

0 references

Adaptive radiation therapy

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

Stephanie E. Combs

object named as

Stephanie E Combs

1

0 references

10

object named as

Jürgen Debus

1 reference

Europe PubMed Central

5 August 2017

Markus Büchler

9

object named as

Markus W Büchler

1 reference

Europe PubMed Central

5 August 2017

Meinhard Kieser

3

object named as

Meinhard Kieser

1 reference

Europe PubMed Central

5 August 2017

author name string

Daniel Habermehl

2

1 reference

Europe PubMed Central

5 August 2017

Constantin Dreher

4

1 reference

Europe PubMed Central

5 August 2017

Jens Werner

5

1 reference

Europe PubMed Central

5 August 2017

Renate Haselmann

6

1 reference

Europe PubMed Central

5 August 2017

Oliver Jäkel

7

1 reference

Europe PubMed Central

5 August 2017

Dirk Jäger

8

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

14 September 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

13

1 reference

Europe PubMed Central

5 August 2017

419

1 reference

Europe PubMed Central

5 August 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-13-419

0 references

A review of update clinical results of carbon ion radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

The clinical experience with particle therapy in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Dose escalation methods in phase I cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Neoadjuvant therapy in pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Particle radiation therapy using proton and heavier ion beams

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Effects of carbon-ion beams on human pancreatic cancer cell lines that differ in genetic status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Tolerance of normal tissue to therapeutic irradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

Pancreatic Cancer Cell DNA Content Correlates With Long-term Survival After Pancreatoduodenectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3849371

8 July 2018

A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-419

21 January 2018

Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-419

21 January 2018

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-419

21 January 2018

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-419

21 January 2018

Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-419

21 January 2018

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-419

21 January 2018

Surgical Treatment of Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-419

21 January 2018

Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24034562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24034562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24034562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic Resections after Chemoradiotherapy for Locally Advanced Ductal Adenocarcinoma: Analysis of Perioperative Outcome and Survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/24034562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24034562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24034562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24034562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-13-419

1 reference

Europe PubMed Central

5 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34986932&oldid=2018553326"